Johnson and Johnson News
News on Johnson and Johnson (Ticker: JNJ) continually updated from thousands of sources around the net.
Yesterday | AlertNet
Leaders of some of the biggest U.S. corporations, from Coca-Cola Co to Johnson & Johnson, unveiled a campaign on Tuesday to reduce the nation's healthcare costs, urging their peers to embrace wellness programs to improve employee health. The newly-formed group, called The CEO Council on Health and Innovation, said it came together "to lead the U.S. business community" in improving employee and community health and reducing costs.
Yesterday | Seeking Alpha
VKTX, a clinical-stage biopharmaceutical firm developing treatments for metabolic and endocrine disorders, plans to raise $55.0 million in its upcoming IPO. Though VKTX does have a broad portfolio of product candidates, none of them are any where near the point of commercialization.
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the January 2017 expiration for JNJ.
Adam Cobb, a management professor at the University of Pennsylvania's Wharton School, suggests that shareholders have gained greater influence in firms while employees' power has waned. And in their hunt for big returns, shareholders-particularly financial investors that purchase large stakes-play an important role in the shrinking pool of pensions.
TKAI, a clinical-stage biopharmaceutical company, engaged in the development of novel treatments for prostate cancer, plans to raise $75.6 million in its upcoming IPO. Tokai Pharmaceuticals Inc , a clinical-stage biopharmaceutical company engaged in the development of novel treatments for prostate cancer, plans to raise $75.6 million in its upcoming IPO.
When she was auditioning for Season 5 of Fox's hit cooking show MasterChef, Elizabeth Cauvel told producers she was an associate creative director at New York-based ad agency MRY, working on Johnson & Johnson brands like Listerine and Band-Aid. Their response: blank stares all around.
MARTHA Salazar's case in Dallas, Texas - the second major victory for mesh victims in America within days - prompts new calls for criminal inquiry in Scotland. Martha Salazar won the huge payout after the court in Dallas, Texas, heard that the Obtryx implant made by Boston Scientific was defective.
Shares in 35 large-cap companies diversified across 17 sectors within Canada and the United States, including Telus, Enbridge, TD, McDonald's, General Mills, Procter & Gamble and Johnson & Johnson. After homeschooling her kids for 17 years, Faye Hamm now works part time and focuses on investing the income she and her husband are putting aside for retirement.
In August 2012 biotech firm Medivation launched prostate cancer drug Xtandi. Since this launch XTANDI has trailed it's competitor in the anti-androgen market, Johnson & Johnson produced Zytiga, due to a more restricted label.
In its latest step to cut costs, Johnson & Johnson JNJ -0.42% will reduce pension benefits that are offered to employees who are hired - or rehired - after Jan. 1, according to an internal memo. The changes, which do not apply to existing employees or retirees, were not detailed, but reflect the way the "benefit landscape has continued to evolve in recent years," as well as "emerging trends" in employee career patterns and practices at competitors, writes Peter Fasolo, the J&J JJSF +0.48% worldwide vice president for human resources.
Expanded Rutgers career fair offers more opportunities Rutgers Career Services' Career & Intership Mega Fair has expanded to two days with a record 300 employers. Check out this story on mycentraljersey.com: http://mycj.co/1tDnojO Rutgers students and alumni recommended that their peers attend the university's expanded Career & Internship Mega Fair, which continues Friday on the Busch Campus.
Janssen Research & Development , a subsidiary of Johnson and Johnson is a pharmaceutical company. The company discovers and develops innovative medicines that ease patients suffering and solve most important unmet medical needs.
Shares in the company's stock have returned 40% this year, outpacing both the S&P 500 index's 10% return and the Nasdaq Biotechnology index's 19% return. That's an impressive performance, particularly for a company boasting a market cap of over $160 billion.
Johnson & Johnson was the target of unusually large options trading on Wednesday. Investors purchased 16,917 call options on the stock, Analyst Ratings Net reports.
Updated: Tue Sep 16, 2014 03:39 pm
Copyright © 2014 Topix LLC